DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Pharmaceutical Market: Saudi Arabia Industry Analysis and Opportunity Assessment, 2016-2026" report to their offering.
This report offers a 10-year forecast of the Saudi Arabia pharmaceutical market between 2016 and 2026. In terms of value, the market is expected to register a CAGR of 9.0% over the forecast period. This study demonstrates market dynamics and trends that influence the current environment and future status of the pharmaceutical market in Saudi Arabia over the forecast period.
The report examines Saudi Arabia pharmaceutical market for the period 2016-2026. The primary objective of the report is to offer insights on various products such as prescription products, branded drugs, generic drugs and over-the-counter (OTC) products.
The report begins by defining various economic and healthcare indicators in the country, followed by an overview of dynamics of the Saudi Arabia pharmaceutical market, which includes analysis of key trends, drivers, restraints and opportunities and key players. It also includes insights into key regulations and reimbursement scenario. Impact analyses of key growth drivers and restraints based on the weighted average model have also been included in the report to better equip readers with meaningful insights on ongoing developments in the market.
Primary factors fuelling growth of the Saudi Arabia pharmaceutical market include increasing population and expatriates coupled with rapidly increasing healthcare infrastructure and proactive measures by the government to improve the healthcare systems in the country. Other factors driving demand for pharmaceuticals in Saudi Arabia are rising prevalence of lifestyle diseases and availability of better quality products from multinational companies.
Report Scope
Key Segments
- Product Type
- Prescription Products
- Branded Drugs
- Generic Drugs
- Over The Counter (OTC) Products
Disease Type
- Cardiovascular Diseases
- Diabetes
- Cancer
- Obesity
- Infectious Diseases
- Other Diseases
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
Key Companies
- SPIMACO
- Tabuk Pharmaceuticals Manufacturing Co.
- Julphar
- Jamjoom Pharma
- Glaxosmithkline plc.
- Pfizer Inc.
- Novartis AG
- Sanofi
Key Topics Covered:
1. Research Methodology
2. Assumptions & Acronyms
3. Executive Summary
4. Saudi Arabia Pharmaceutical Market Overview
5. Saudi Arabia Pharmaceutical Market-Healthcare Indicators
6. Market Dynamics
7. Saudi Arabia Pharmaceuticals Market, By Product Type
8. Saudi Arabia Pharmaceuticals Market, By Disease Type
9. Saudi Arabia Pharmaceuticals Market, By Distribution Channel
10. Competition Landscape
For more information about this report visit http://www.researchandmarkets.com/research/w5xzs5/pharmaceutical
Related Topics: Pharmaceuticals
